Is Omicron really mild? – Comparative analysis of comorbidities and disease outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants

[1]  J. Baillie,et al.  Comorbidities, multimorbidity and COVID-19 , 2023, Nature Medicine.

[2]  K. C. Gouda,et al.  Impact of comorbidity on patients with COVID-19 in India: A nationwide analysis , 2023, Frontiers in Public Health.

[3]  L. Danon,et al.  Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom , 2022, The Lancet Regional Health - Europe.

[4]  Prof Vikas Kumar,et al.  SARS-CoV-2 infection related mortality and comorbidities in a dedicated COVID-19 facility: A record based analysis from Uttar Pradesh , 2022, Asian Journal of Medical Sciences.

[5]  S. Bhatt,et al.  Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study , 2022, The Lancet.

[6]  N. Daneman,et al.  Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada. , 2022, JAMA.

[7]  Sirajudheen Anwar,et al.  The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It , 2022, Saudi Journal of Biological Sciences.

[8]  A. Sigal.  Milder disease with Omicron: is it the virus or the pre-existing immunity? , 2022, Nature Reviews Immunology.

[9]  C. Zheng,et al.  Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines , 2022, Journal of medical virology.

[10]  Myung‐hee Lee,et al.  Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea , 2022, Journal of Korean medical science.

[11]  Ja-Hwan Seol,et al.  Evaluation of Three Automated Extraction Systems for the Detection of SARS-CoV-2 from Clinical Respiratory Specimens , 2022, Life.

[12]  C. Maslo,et al.  Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves. , 2021, JAMA.

[13]  S. Polipalli,et al.  Amplicon-based nanopore minion sequencing of patients with COVID-19 omicron variant from India , 2021, medRxiv.

[14]  J. Bhiman,et al.  Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa , 2021, medRxiv.

[15]  Joshua B. Singer,et al.  Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study , 2021, The Lancet Infectious Diseases.

[16]  S. Hasnain,et al.  SARS-CoV-2 variants of concern are emerging in India , 2021, Nature Medicine.

[17]  Yuzhang Wu,et al.  Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection , 2021, Nature Communications.

[18]  M. Cascella,et al.  Features, Evaluation, and Treatment of Coronavirus , 2020 .

[19]  E. Asirvatham,et al.  Who is dying from COVID-19 and when? An Analysis of fatalities in Tamil Nadu, India , 2020, Clinical Epidemiology and Global Health.

[20]  K. Khunti,et al.  Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study , 2020, The Lancet Diabetes & Endocrinology.

[21]  G. Lippi,et al.  Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. , 2020, Polish archives of internal medicine.

[22]  C. Vardavas,et al.  COVID-19 and smoking: A systematic review of the evidence , 2020, Tobacco induced diseases.

[23]  Xiaolong Qi,et al.  Real estimates of mortality following COVID-19 infection , 2020, The Lancet Infectious Diseases.

[24]  B. Jiang,et al.  Comorbidities and multi-organ injuries in the treatment of COVID-19 , 2020, The Lancet.

[25]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[26]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[27]  Wei Wang,et al.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.